Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.4 USD | -0.31% | -3.99% | +11.00% |
Sales 2024 * | 431M 591M | Sales 2025 * | 653M 896M | Capitalization | 6.41B 8.8B |
---|---|---|---|---|---|
Net income 2024 * | -152M -209M | Net income 2025 * | -104M -143M | EV / Sales 2024 * | 13.7 x |
Net cash position 2024 * | 514M 705M | Net cash position 2025 * | 444M 610M | EV / Sales 2025 * | 9.14 x |
P/E ratio 2024 * |
-46
x | P/E ratio 2025 * |
-62.4
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.98% | Free-Float | 99.1% |
Latest transcript on Blueprint Medicines Corporation
1 day | -0.31% | ||
1 week | -3.99% | ||
Current month | +12.10% | ||
1 month | +10.94% | ||
3 months | +14.42% | ||
6 months | +52.80% | ||
Current year | +11.00% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 102.4 | -0.31% | 551,246 |
24-05-22 | 102.7 | -0.89% | 385,996 |
24-05-21 | 103.6 | -0.60% | 423,398 |
24-05-20 | 104.3 | -0.67% | 468,869 |
24-05-17 | 105 | -1.58% | 415,572 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.00% | 6.41B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+46.17% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- BPMC Stock